Evidence map›Paper›PMID 37288668›Full record

ArticleMolecular genetics & genomic medicine2023

Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease.

Yongxiang Wang, Ming Bai, Piyi Zhang, Yu Peng, Zixian Chen, Zhiyu He, Jin Xu, Youqi Zhu, Dongdong Yan, Runqing Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Cancer-associated TRF1 mutations alter PARP1 interaction dynamics: an in silico study.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  3. A novelFrontiers in cardiovascular medicine · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yongxiang WangHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.ORCID 0000-0002-4764-3682
Ming BaiHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Piyi ZhangHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Yu PengHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Zixian ChenHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Zhiyu HeHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Jin XuHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Youqi ZhuHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Dongdong YanHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Runqing WangHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Zheng ZhangHeart Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Gansu Provincial Hospital · CNFirst Hospital of Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDanon disease is characterized by the failure of lysosomal biogenesis, maturation, and function due to a deficiency of lysosomal membrane structural protein (LAMP2).

methodsThe current report describes a female patient with a sudden syncope and hypertrophic cardiomyopathy phenotype. We identified the pathogenic mutations in patients by whole-exon sequencing, followed by a series of molecular biology and genetic approaches to identify and functional analysis of the mutations.

resultsSuggestive findings by cardiac magnetic resonance (CMR), electrocardiogram (ECG), and laboratory examination suggested Danon disease which was confirmed by genetic testing. The patient carried a novel de novo mutation, LAMP2 c.2T>C located at the initiation codon. The quantitative polymerase chain reaction (qPCR) and Western blot (WB) analysis of peripheral blood leukocytes from the patients revealed evidence of LAMP2 haploinsufficiency. Labeling of the new initiation codon predicted by the software with green fluorescent protein followed by fluorescence microscopy and Western blotting showed that the first ATG downstream from the original initiation codon became the new translational initiation codon. The three-dimensional structure of the mutated protein predicted by alphafold2 revealed that it consisted of only six amino acids and failed to form a functional polypeptide or protein. Overexpression of the mutated LAMP2 c.2T>C showed a loss of function of the protein, as assessed by the dual-fluorescence autophagy indicator system. The mutation was confirmed to be null, AR experiments and sequencing results confirmed that 28% of the mutant X chromosome remained active.

conclusionWe propose possible mechanisms of mutations associated with haploinsufficiency of LAMP2: (1) The inactivation X chromosome carrying the mutation was not significantly skewed. However, it decreased in the mRNA level and the expression ratio of the mutant transcripts; (2) The identified mutation is null, and the active mutant transcript fails to translate into the normal LAMP2 proteins. The presence of haploinsufficiency in LAMP2 and the X chromosome inactivation pattern were crucial factors contributing to the early onset of Danon disease in this female patient.

Indexed as

Cardiomyopathy, HypertrophicGlycogen Storage Disease Type IIbCodon, InitiatorFemaleHumansLysosomal-Associated Membrane Protein 2MutationMutation, MissenseCodon, InitiatorLAMP2 protein, humanLysosomal-Associated Membrane Protein 2autophagyDanon diseasehaploinsufficiencyinitiation codon mutationlysosome-associated membrane glycoprotein 2X chromosome inactivation

Identifiers

PMID37288668
PMCPMC10496070
OpenAlexW4379768413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.